Sun Pharmaceutical Industries has announced the acquisition of US-based Organon & Co in an all-cash deal valued at $11.75 billion, including debt, marking one of the largest outbound acquisitions by an Indian pharmaceutical company. As part of the transaction, Sun Pharma will acquire all outstanding shares of Organon at $14 per share, representing a premium … Continue reading Sun Pharma to Acquire Organon in $11.75 Billion Deal, Expands Women’s Health Portfolio